Effects of a Chronic Lithium Treatment on Cortical Serotonin Uptake Sites and 5-HT1A Receptors

被引:0
作者
Martin Carli
Soheila Afkhami-Dastjerdian
Tomás A. Reader
机构
[1] Université de Montréal,Centre de Recherche en Sciences Neurologiques, Faculté de Médecine
[2] Université de Montréal,Centre de Recherche en Sciences Neurologiques Département de Physiologie, Faculté de Médecine
[3] Succursale Centreville,undefined
来源
Neurochemical Research | 1997年 / 22卷
关键词
Lithium; serotonin uptake; 5-HT; receptor;
D O I
暂无
中图分类号
学科分类号
摘要
The objectives of this study were to characterize the effects of a chronic lithium (Li+) treatment on serotonin (5-HT) uptake sites and on 5-HT1A receptors, and to determine the eventual reversibility of the treatment. The experiments were carried out with membranes from rat cerebral cortex using 8-hydroxy-2-(propylamino)tetralin, or [3H]8-OH-DPAT, and [3H]citalopram to label 5-HT1A receptors and 5-HT uptake sites, respectively. Endogenous levels of 5-HT and 5-hydroxyindole-3-acetic acid (5-HIAA) were measured by high-performance liquid chromatography in the cingulate cortex. The saturation curves with [3H]8-OH-DPAT were always best fitted a two-site model. After a treatment with Li+ for 28 days, no alterations in the binding parameters of [3H]8-OH-DPAT to the high- and low-affinity binding sites could be documented. However, competition curves with 5-HT to inhibit [3H]8-OH-DPAT binding revealed a decreased proportion of sites with high affinity for the agonist, together with an increased density of sites with low affinity for 5-HT, suggesting an alteration in the coupling efficacy between 5-HT1A receptors and their transduction systems. Saturation studies with [3H]citalopram showed an increase (>40%) in the density of 5-HT uptake sites after chronic Li+, suggesting a more efficient 5-HT uptake process for the treated animals, in accord with clinical observations. Although 5-HT contents in cingulate cortex remained unchanged after the treatment, 5-HIAA levels decreased (>30%), leading to a diminished (almost 50%) 5-HT turnover; and also reflecting a more efficient uptake in the treated rats, so that less 5-HT could be degraded by extracellular monoamine oxidase. All the effects revealed by [3H]8-OH-DPAT and [3H]citalopram were reversed following a recovery period of two days without Li+. Since symptoms of bipolar affective disorders may reappear if the chronic Li+ treatment is interrupted, the reversibility of the observed effects further supports the importance of central 5-HT synaptic transmission in the pathophysiology and treatment of human affective disorders.
引用
收藏
页码:427 / 435
页数:8
相关论文
共 142 条
[1]  
Cade J. F. J.(1949)Lithium salts in the treatment of psychotic excitement Med. J. Aust. 36 349-352
[2]  
Schildkraut J. J.(1965)The catecholamine hypothesis of affective disorders: a review of supporting evidence Am. J. Psychiat. 122 509-522
[3]  
Schildkraut J. J.(1966)The effects of lithium ions on Life Sci. 5 1479-1483
[4]  
Schanberg S. M.(1967)H-norepinephrine metabolism in brain Brit. J. Psychiat. 113 1237-1264
[5]  
Kopin I. J.(1974)The biochemistry of affective disorder Arch. Gen. Psychiat. 30 56-62
[6]  
Coppen A. J.(1983)L-tryptophan in mania: contribution to a permissive hypothesis of affective disorders Brit. J. Clin. Pharmacol. 15 393S-405S
[7]  
Prange A. J.(1983)5-Hydroxytryptamine and depression: a model for the interaction of normal variance with pathology Arch. Gen. Psychiat. 40 1327-1334
[8]  
Wilson I. C.(1983)Lithium carbonate addition in tricyclic antidepressant-resistant depression: correlations with the neurobiologic actions of tricyclic antidepressant drugs and the lithium ion on the serotonin system Arch. Gen. Psychiat. 40 1335-1342
[9]  
Lynn C. W.(1990)Lithium carbonate augmentation of antidepressant treatment: an effective prescription for treatment-refractory depression Psychopharmacol. 100 3-12
[10]  
Goodwin F. K.(1977)Lithium and serotonin function: implications for the serotonin hypothesis of depression Biochem. Pharmacol. 26 167-180